CSL Limited (OTCMKTS:CSLLY) Sees Significant Growth in Short Interest

CSL Limited (OTCMKTS:CSLLY) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 4,700 shares, a growth of 683.3% from the November 30th total of 600 shares. Based on an average daily volume of 102,500 shares, the days-to-cover ratio is presently 0.0 days.

CSL Trading Down 0.2 %

Shares of OTCMKTS:CSLLY opened at $88.56 on Friday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.97 and a current ratio of 2.18. The firm has a fifty day moving average price of $92.02 and a 200 day moving average price of $97.54. CSL has a fifty-two week low of $83.31 and a fifty-two week high of $109.00.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.